1129 related articles for article (PubMed ID: 19746889)
1. [Irritant contact dermatitis. Part II. Evaluation evaluation of skin irritation potential of chemicals].
Chomiczewska D; Kieć-Swierczyńska M; Krecisz B
Med Pr; 2009; 60(3):209-14. PubMed ID: 19746889
[TBL] [Abstract][Full Text] [Related]
2. [Irritant contact dermatitis. Part III. Non-invasive methods to assess biophysical properties of the skin].
Chomiczewska D; Kieć-Swierczyńska M; Krecisz B
Med Pr; 2010; 61(4):457-66. PubMed ID: 20865858
[TBL] [Abstract][Full Text] [Related]
3. In vitro irritation models and immune reactions.
Gibbs S
Skin Pharmacol Physiol; 2009; 22(2):103-13. PubMed ID: 19188758
[TBL] [Abstract][Full Text] [Related]
4. The usefulness of toxicogenomics for predicting acute skin irritation on in vitro reconstructed human epidermis.
Borlon C; Godard P; Eskes C; Hartung T; Zuang V; Toussaint O
Toxicology; 2007 Nov; 241(3):157-66. PubMed ID: 17928126
[TBL] [Abstract][Full Text] [Related]
5. Determination of skin irritation potential in the human 4-h patch test.
Basketter DA; York M; McFadden JP; Robinson MK
Contact Dermatitis; 2004 Jul; 51(1):1-4. PubMed ID: 15291823
[TBL] [Abstract][Full Text] [Related]
6. Skin irritation and sensitization: mechanisms and new approaches for risk assessment. 1. Skin irritation.
Fluhr JW; Darlenski R; Angelova-Fischer I; Tsankov N; Basketter D
Skin Pharmacol Physiol; 2008; 21(3):124-35. PubMed ID: 18523410
[TBL] [Abstract][Full Text] [Related]
7. A tiered approach to the use of alternatives to animal testing for the safety assessment of cosmetics: skin irritation.
Macfarlane M; Jones P; Goebel C; Dufour E; Rowland J; Araki D; Costabel-Farkas M; Hewitt NJ; Hibatallah J; Kirst A; McNamee P; Schellauf F; Scheel J
Regul Toxicol Pharmacol; 2009 Jul; 54(2):188-96. PubMed ID: 19393278
[TBL] [Abstract][Full Text] [Related]
8. Optimisation of the EpiDerm test protocol for the upcoming ECVAM validation study on in vitro skin irritation tests.
Kandárová H; Liebsch M; Genschow E; Gerner I; Traue D; Slawik B; Spielmann H
ALTEX; 2004; 21(3):107-14. PubMed ID: 15329774
[TBL] [Abstract][Full Text] [Related]
9. Leiden reconstructed human epidermal model as a tool for the evaluation of the skin corrosion and irritation potential according to the ECVAM guidelines.
El Ghalbzouri A; Siamari R; Willemze R; Ponec M
Toxicol In Vitro; 2008 Aug; 22(5):1311-20. PubMed ID: 18474418
[TBL] [Abstract][Full Text] [Related]
10. [Cosmetic allergy].
Wojciechowska M; Gocki J; Bartuzi Z
Pol Merkur Lekarski; 2008 Jul; 25(145):87-9. PubMed ID: 18839623
[TBL] [Abstract][Full Text] [Related]
11. In vitro skin irritation: facts and future. State of the art review of mechanisms and models.
Welss T; Basketter DA; Schröder KR
Toxicol In Vitro; 2004 Jun; 18(3):231-43. PubMed ID: 15046769
[TBL] [Abstract][Full Text] [Related]
12. [Irritant contact dermatitis. Part I. Epidemiology, etiopathogenesis and clinical manifestation].
Chomiczewska D; Kieć-Swierczyńska M; Krecisz B
Med Pr; 2008; 59(5):409-19. PubMed ID: 19227886
[TBL] [Abstract][Full Text] [Related]
13. Skin irritation and sensitization: mechanisms and new approaches for risk assessment.
Basketter D; Darlenski R; Fluhr JW
Skin Pharmacol Physiol; 2008; 21(4):191-202. PubMed ID: 18509253
[TBL] [Abstract][Full Text] [Related]
14. Comparison of human skin irritation patch test data with in vitro skin irritation assays and animal data.
Jírová D; Basketter D; Liebsch M; Bendová H; Kejlová K; Marriott M; Kandárová H
Contact Dermatitis; 2010 Feb; 62(2):109-16. PubMed ID: 20136894
[TBL] [Abstract][Full Text] [Related]
15. The ECVAM international validation study on in vitro tests for acute skin irritation: report on the validity of the EPISKIN and EpiDerm assays and on the Skin Integrity Function Test.
Spielmann H; Hoffmann S; Liebsch M; Botham P; Fentem JH; Eskes C; Roguet R; Cotovio J; Cole T; Worth A; Heylings J; Jones P; Robles C; Kandárová H; Gamer A; Remmele M; Curren R; Raabe H; Cockshott A; Gerner I; Zuang V
Altern Lab Anim; 2007 Dec; 35(6):559-601. PubMed ID: 18186667
[TBL] [Abstract][Full Text] [Related]
16. The vulvar epithelium differs from the skin: implications for cutaneous testing to address topical vulvar exposures.
Farage M; Maibach HI
Contact Dermatitis; 2004 Oct; 51(4):201-9. PubMed ID: 15500670
[TBL] [Abstract][Full Text] [Related]
17. Read-across to rank skin sensitization potential: subcategories for the Michael acceptor domain.
Schultz TW; Rogers K; Aptula AO
Contact Dermatitis; 2009 Jan; 60(1):21-31. PubMed ID: 19125718
[TBL] [Abstract][Full Text] [Related]
18. Development of a sensitive test method to evaluate mechanical irritation potential on mucosal skin.
Farage MA; Meyer S; Walter D
Skin Res Technol; 2004 May; 10(2):85-95. PubMed ID: 15059175
[TBL] [Abstract][Full Text] [Related]
19. A prevalidation study on in vitro tests for acute skin irritation. results and evaluation by the Management Team.
Fentem JH; Briggs D; Chesné C; Elliott GR; Harbell JW; Heylings JR; Portes P; Roguet R; van de Sandt JJ; Botham PA
Toxicol In Vitro; 2001 Feb; 15(1):57-93. PubMed ID: 11259870
[TBL] [Abstract][Full Text] [Related]
20. An in vitro method for detecting chemical sensitization using human reconstructed skin models and its applicability to cosmetic, pharmaceutical, and medical device safety testing.
McKim JM; Keller DJ; Gorski JR
Cutan Ocul Toxicol; 2012 Dec; 31(4):292-305. PubMed ID: 22494060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
